FOI 4025 Melanoma

Within your health trust how many patients are currently [within the past 6 months] being treated for Melanoma? 82

 

Of these Melanoma patients how many are being treated for stage IV (advanced or metastatic) melanoma? Royal Surrey County Hospital NHS Foundation Trust does not hold this information centrally and therefore would have scrutinise each healthcare record to provide this response. This would take above and beyond the time restrictions under Section 12 of the Freedom of Information Act.

 

Of these how many are being treated for (advanced or metastatic) melanoma with the following; Royal Surrey County Hospital NHS Foundation Trust can only provide data for the total number of patients under the care of oncology issued with the agents listed. It is not possible for The Trust to separate data by indication as this is not recorded at the point of dispensing. The data will therefore include patients who have been treated with these drugs for other indications as these drugs may be used for various different cancers.

 

Drug Name Number of Patients
Ipilimumab (Yervoy) single agent 11
Ipilimumab (Yervoy) in combination 0
Nivolumab (Opdivo) 13
Pembrolizumab (Keytruda) 79
vemurafenib (Zelboraf) single agent 0
vemurafenib (Zelboraf) in combination 0
dabrafenib (Taflinar) 13
trametinib (Mekinist) 0
dabrafenib AND trametinib 0
dacarbazine (DTIC) 2

 

How many patients are currently [within the past 6 months] being treated for Non Squamous Cell Lung Cancer with the following; Royal Surrey County Hospital NHS Foundation Trust can only provide data for the total number of patients under the care of oncology issued with the agents listed. It is not possible for The Trust to separate data by indication as this is not recorded at the point of dispensing. The data will therefore include patients who have been treated with these drugs for other indications as these drugs may be used for various different cancers.

 

Drug Name Number of Patients
Afatinib (Giotrif)                 18
Ceritinib (Zykadia) 3
Crizotinib (Xalkori)  8
Erlotinib (Tarceva)   0
Gefitinib (Iressa)         19
Pemetrexed (Alimta) 66
Nivolumab (Opdivo) 13
Pembrolizumab (Keytruda) 79

 

How many patients are currently [within the past 6 months] being treated for Renal Cell Carcinoma (RCC) with the following; Royal Surrey County Hospital NHS Foundation Trust can only provide data for the total number of patients under the care of oncology issued with the agents listed. It is not possible for The Trust to separate data by indication as this is not recorded at the point of dispensing. The data will therefore include patients who have been treated with these drugs for other indications as these drugs may be used for various different cancers.

Drug Name Number of Patients
Interferon (Intron A) 0
Bevacizumab (Avastin) 68
Sunitinib (Sutent) 35
Pazopanib (Votrient) 34
Aldesleukin (IL-2, Proleukin or interleukin 2) 0
Sorafenib (Nexavar) 22
Everolimus (Afinitor) 17
Temsirolimus (Torisel) 0
Cabozantinib (Cometriq) 7

 

 

©2017 Royal Surrey County Hospital

Log in with your credentials

Forgot your details?